'spect many are perplexed...
If Dew saw anything 'sinister', he would have already posted.
He and others have been buying...
market sentiment is decidedly negative, that coupled with 'shock' of the NM283 hold and program termination just 1 month after the announcement of no interaction w/ ribavirin and no obvious concern NM283 safety @ that time...
In the long run, I expect it was better for NM283 to be terminated now. In addtion to the risk/ benefit analysis completed by the FDA, I am sure NVS did a cost / benefit analysis.
Bottom line... investors do not like disappointment and, at times, they have a tendency to 'throw the baby out with the bath water.'
the choices are buy, sell, or hold...
take care
News 
Market Data 
Discover 
